Anticholinergic use in children: Persistence and patterns of therapy.

about

Bladder and bowel dysfunction in children: An update on the diagnosis and treatment of a common, but underdiagnosed pediatric problem.Overactive bladder in children.Pharmacotherapy for Pediatric Neurogenic Bladder.

P2860

Q39164664-DB40EE44-274E-49EA-AC07-308CA0B146BB Q39164669-A4DC4CEC-DFA2-41DF-9C25-680F75F3AC2F Q39437361-D1C9B755-F1CE-4D5E-B232-871424193917

P2860

Anticholinergic use in children: Persistence and patterns of therapy.

Item

http://www.wikidata.org/entity/Q36823081

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Anticholinergic use in children: Persistence and patterns of therapy.

@en

type

Item

label

Anticholinergic use in children: Persistence and patterns of therapy.

@en

prefLabel

Anticholinergic use in children: Persistence and patterns of therapy.

@en

P1476

Anticholinergic use in children: Persistence and patterns of therapy.

@en

P2093

Anne-Sophie Blais

http://www.w3.org/2001/XMLSchema#string

Geneviève Nadeau

http://www.w3.org/2001/XMLSchema#string

Michelle Bergeron

http://www.w3.org/2001/XMLSchema#string

Sophie Ramsay

http://www.w3.org/2001/XMLSchema#string

Stéphane Bolduc

http://www.w3.org/2001/XMLSchema#string

P2860

Use of tolterodine in children with dysfunctional voiding: an initial report.

The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society.

Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review.

Efficacy and safety of propiverine in children with overactive bladder.

4. Bedwetting and toileting problems in children.

Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin.

Pediatric overactive bladder syndrome: pathophysiology and management.

Update on tolterodine extended-release for treatment of overactive bladder

Long-term use of solifenacin in pediatric patients with overactive bladder: Extension of a prospective open-label study.

Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial.

P304

137-140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5489/CUAJ.3527

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27217862

http://www.w3.org/2001/XMLSchema#string

P932

4839996

http://www.w3.org/2001/XMLSchema#string

Anticholinergic use in children: Persistence and patterns of therapy.

about

P2860

P2860

Anticholinergic use in children: Persistence and patterns of therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932